Structural Investigations of N3-(2-Hydroxy-3-buten-1-yl)-2'-deoxyuridine DNA Adducts

Butadiene monoepoxide (BDO) is the major metabolite of butadiene (BD), a widely used petrochemical and known human and animal carcinogen. BD metabolites may be involved in BD-induced carcinogenicity primarily through the production of DNA adducts. Under physiological conditions, BDO alkylates the N3...

Full description

Bibliographic Details
Main Author: Musser, Sarah Kipley
Other Authors: Professor Michael P. Stone
Format: Others
Language:en
Published: VANDERBILT 2009
Subjects:
Online Access:http://etd.library.vanderbilt.edu//available/etd-07222009-161202/
id ndltd-VANDERBILT-oai-VANDERBILTETD-etd-07222009-161202
record_format oai_dc
spelling ndltd-VANDERBILT-oai-VANDERBILTETD-etd-07222009-1612022013-01-08T17:16:50Z Structural Investigations of N3-(2-Hydroxy-3-buten-1-yl)-2'-deoxyuridine DNA Adducts Musser, Sarah Kipley Chemistry Butadiene monoepoxide (BDO) is the major metabolite of butadiene (BD), a widely used petrochemical and known human and animal carcinogen. BD metabolites may be involved in BD-induced carcinogenicity primarily through the production of DNA adducts. Under physiological conditions, BDO alkylates the N3 of deoxycytidine yielding stereoisomeric N3-(2-hydroxy-3-buten-1-yl)-2f-deoxycytidine adducts. These adducts are relatively unstable leading to hydrolytic deamination, forming stereoisomeric N3-(2-hydroxy-3-buten-1-yl)-2f-deoxyuridine (BD-N3-dU) adducts. Although, the BD-N3-dU adducts have not been isolated in vivo, suggesting a low-level occurrence in cellular DNA, they are highly mutagenic in mammalian cells. Mutagenesis studies, which revealed that the major mutations were C¨T transitions and C¨A transversions, also showed stereospecific differences in mutagenic frequencies. In the presence of the R adduct, there was a 2:1 preference for the insertion of dA vs. dT opposite the lesion. Whereas, in the presence of the S adduct, dA and dT were inserted at the same mutagenic frequency. It was hypothesized that structural differences in the orientation of the BD moiety may play a role in the differences observed in the mutagenesis results. Solution structures of R- and S-BD-N3-dU modified oligonucleotides, placing the modified nucleotides opposite dA and dT, were solved using NMR spectroscopy. These models represent the C¨T and C¨A mutations, respectively. NMR analysis revealed structural differences at the lesion site for the R-BD-N3-dU adduct when placed opposite dA vs. dT. For the S-BD-N3-dU adduct, however, the butadiene moieties assumed similar orientations when placed opposite dA and dT. These observations in duplex DNA correlate to the mutagenesis results and suggest that the orientation of the butadiene moiety may play a role in biological processing. Biochemical analyses of the BD-N3-dU adducts indicated the role of polymerase eta in the insertion of primarily dA and dG opposite the lesion site. NMR solution structures of the R- and S-BD-N3-dU modified nucleotides placed opposite dG, revealed that the butadiene moieties were oriented similarly when placed opposite dA. Again, suggesting a structural influence in DNA replication. X-ray crystallographic studies involving pol eta and incoming dNTPs will provide further insight into the mutagenicity of the R- and S-BD-N3-dU adducts. Professor Michael P. Stone Professor Terry P. Lybrand Professor Carmelo J. Rizzo Professor Brian O. Bachmann VANDERBILT 2009-07-25 text application/pdf http://etd.library.vanderbilt.edu//available/etd-07222009-161202/ http://etd.library.vanderbilt.edu//available/etd-07222009-161202/ en unrestricted I hereby certify that, if appropriate, I have obtained and attached hereto a written permission statement from the owner(s) of each third party copyrighted matter to be included in my thesis, dissertation, or project report, allowing distribution as specified below. I certify that the version I submitted is the same as that approved by my advisory committee. I hereby grant to Vanderbilt University or its agents the non-exclusive license to archive and make accessible, under the conditions specified below, my thesis, dissertation, or project report in whole or in part in all forms of media, now or hereafter known. I retain all other ownership rights to the copyright of the thesis, dissertation or project report. I also retain the right to use in future works (such as articles or books) all or part of this thesis, dissertation, or project report.
collection NDLTD
language en
format Others
sources NDLTD
topic Chemistry
spellingShingle Chemistry
Musser, Sarah Kipley
Structural Investigations of N3-(2-Hydroxy-3-buten-1-yl)-2'-deoxyuridine DNA Adducts
description Butadiene monoepoxide (BDO) is the major metabolite of butadiene (BD), a widely used petrochemical and known human and animal carcinogen. BD metabolites may be involved in BD-induced carcinogenicity primarily through the production of DNA adducts. Under physiological conditions, BDO alkylates the N3 of deoxycytidine yielding stereoisomeric N3-(2-hydroxy-3-buten-1-yl)-2f-deoxycytidine adducts. These adducts are relatively unstable leading to hydrolytic deamination, forming stereoisomeric N3-(2-hydroxy-3-buten-1-yl)-2f-deoxyuridine (BD-N3-dU) adducts. Although, the BD-N3-dU adducts have not been isolated in vivo, suggesting a low-level occurrence in cellular DNA, they are highly mutagenic in mammalian cells. Mutagenesis studies, which revealed that the major mutations were C¨T transitions and C¨A transversions, also showed stereospecific differences in mutagenic frequencies. In the presence of the R adduct, there was a 2:1 preference for the insertion of dA vs. dT opposite the lesion. Whereas, in the presence of the S adduct, dA and dT were inserted at the same mutagenic frequency. It was hypothesized that structural differences in the orientation of the BD moiety may play a role in the differences observed in the mutagenesis results. Solution structures of R- and S-BD-N3-dU modified oligonucleotides, placing the modified nucleotides opposite dA and dT, were solved using NMR spectroscopy. These models represent the C¨T and C¨A mutations, respectively. NMR analysis revealed structural differences at the lesion site for the R-BD-N3-dU adduct when placed opposite dA vs. dT. For the S-BD-N3-dU adduct, however, the butadiene moieties assumed similar orientations when placed opposite dA and dT. These observations in duplex DNA correlate to the mutagenesis results and suggest that the orientation of the butadiene moiety may play a role in biological processing. Biochemical analyses of the BD-N3-dU adducts indicated the role of polymerase eta in the insertion of primarily dA and dG opposite the lesion site. NMR solution structures of the R- and S-BD-N3-dU modified nucleotides placed opposite dG, revealed that the butadiene moieties were oriented similarly when placed opposite dA. Again, suggesting a structural influence in DNA replication. X-ray crystallographic studies involving pol eta and incoming dNTPs will provide further insight into the mutagenicity of the R- and S-BD-N3-dU adducts.
author2 Professor Michael P. Stone
author_facet Professor Michael P. Stone
Musser, Sarah Kipley
author Musser, Sarah Kipley
author_sort Musser, Sarah Kipley
title Structural Investigations of N3-(2-Hydroxy-3-buten-1-yl)-2'-deoxyuridine DNA Adducts
title_short Structural Investigations of N3-(2-Hydroxy-3-buten-1-yl)-2'-deoxyuridine DNA Adducts
title_full Structural Investigations of N3-(2-Hydroxy-3-buten-1-yl)-2'-deoxyuridine DNA Adducts
title_fullStr Structural Investigations of N3-(2-Hydroxy-3-buten-1-yl)-2'-deoxyuridine DNA Adducts
title_full_unstemmed Structural Investigations of N3-(2-Hydroxy-3-buten-1-yl)-2'-deoxyuridine DNA Adducts
title_sort structural investigations of n3-(2-hydroxy-3-buten-1-yl)-2'-deoxyuridine dna adducts
publisher VANDERBILT
publishDate 2009
url http://etd.library.vanderbilt.edu//available/etd-07222009-161202/
work_keys_str_mv AT mussersarahkipley structuralinvestigationsofn32hydroxy3buten1yl2deoxyuridinednaadducts
_version_ 1716570359559356416